These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 456389)
1. Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Report of a case associated with nontoxic plasma levels of diphenylhydantoin. Mauguière F; Dalery J; de Villard R; Courjon J Eur Neurol; 1979; 18(2):116-23. PubMed ID: 456389 [TBL] [Abstract][Full Text] [Related]
2. Neurotransmitter metabolites in medicated epileptic patients. Markianos M; Kalfakis N Funct Neurol; 1991; 6(4):367-70. PubMed ID: 1725777 [TBL] [Abstract][Full Text] [Related]
8. [Value of anticonvulsant level determination in the treatment of epilepsies]. Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087 [TBL] [Abstract][Full Text] [Related]
9. [Epidemiological observations on plasma levels of diphenylhydantoin in 130 patients on prolonged treatment (author's tranls)]. Frigo GM; Perucca E; Teggia-Droghi M; Gatti G; Visintini D; Calzetti S; Poloni M Riv Patol Nerv Ment; 1976; 97(5):305-14. PubMed ID: 1032214 [TBL] [Abstract][Full Text] [Related]
10. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate]. Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166 [No Abstract] [Full Text] [Related]
11. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences. Raleigh MJ; Brammer GL; McGuire MT; Pollack DB; Yuwiler A Neuropsychopharmacology; 1992 Dec; 7(4):295-304. PubMed ID: 1282317 [TBL] [Abstract][Full Text] [Related]
12. [Paroxysmal dyskinesia during treatment with diphenylhydantoin]. Dravet C; Dalla Bernardina B; Mesdjian E; Galland MC; Roger J Rev Neurol (Paris); 1980; 136(1):1-14. PubMed ID: 7394437 [TBL] [Abstract][Full Text] [Related]
13. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone. Borst SI; Lockwood CH Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131 [TBL] [Abstract][Full Text] [Related]
15. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus. Inagawa T; Ishikawa S; Uozumi T J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788 [TBL] [Abstract][Full Text] [Related]
16. Effects of diphenylhydantoin in 41 epileptics institutionalized since childhood. Herberg KP South Med J; 1977 Jan; 70(1):19-24. PubMed ID: 190707 [TBL] [Abstract][Full Text] [Related]
17. Overnight sleep EEG and cerebrospinal fluid monoamines in seizures induced by movement. Fukuyama Y; Ochiai Y; Hayakawa T; Miyagawa F Neuropadiatrie; 1979 May; 10(2):138-49. PubMed ID: 226908 [TBL] [Abstract][Full Text] [Related]
18. [Determination of HVA and 5-HIAA in epileptic syndromes in basal conditions and after treatment with probenecid]. Carrieri P; Orefice G; Mandarini A; Rossi V; Campanella G Acta Neurol Quad (Napoli); 1979; 39():42-7. PubMed ID: 95499 [No Abstract] [Full Text] [Related]
19. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system. González-Quevedo A; García JC; Fernández R; Fernández Cartaya L Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168 [TBL] [Abstract][Full Text] [Related]
20. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)]. Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]